We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Ensign Group (ENSG) Hits 52 Week High: Will the Rally Continue?
Read MoreHide Full Article
On Dec 7, shares of The Ensign Group, Inc. (ENSG - Free Report) touched a 52-week high of $73.98 before closing the session a tad lower at $73.87.
This upside can be attributed to investors’ confidence in the company’s ability to gain from its strong inorganic story that it has created over the past decade. In fact, investors’ optimism was buoyed by the company’s 2020 guidance raise despite the current economic scenario.
For the full year, earnings guidance is expected between $3.04 and $3.12, up from the previous view of $3-$3.10. The midpoint of this lifted outlook indicates a 58% rise from the 2019 adjusted results.
What’s Driving This Outperformance?
Recently, the company completed the buyout of operations of a San Marcos, TX-based skilled nursing facility, which contains 116 beds. The inclusion of Hays Nursing and Rehabilitation Center brings the total count of healthcare operations in the company’s portfolio to 228, which is spread across 13 states. Subject to a long-term, triple net lease, the transaction has already been effective since Dec 1, 2020. Significantly, last month, the company bought the real estate and operations of a Texas-based skilled nursing facility named The Medical Lodge of Amarillo.
It used acquisitions to supplement its organic efforts. These buyouts also proved to be accretive to its revenues and allowed it to grow in scale and size. The company’s historical growth is mainly driven by its expertise in acquiring real estate or leasing post-acute care operations and transforming the same into market leaders. Each acquisition sharpened its efficiency, both clinically and financially.
Ensign Group continues to actively seek transactions to purchase real estate and to lease both well-performing and struggling skilled nursing, assisted living and other healthcare-related businesses in the new and existing markets. There are already several buyouts in its pipeline, which are expected to close in the fourth quarter of 2020 and early 2021.
Its top line has been growing on the back of both its Medicaid and Medicare businesses. It also anticipates 2020 annual revenues in the band of $2.42-$2.45 billion, the midpoint implying an upside of 6.3% from the year-ago reported figure.
Ensign Group is well poised for growth owing to its strategic measures as well as a solid capital position.
We believe that these efforts will continue to augur well for the company in the long haul.
Its earnings estimate stands at $3.06, suggesting a 36.6% surge from the prior-year reported number.
The company carries a Zacks Rank #3 (Hold ), currently. Over the past year, the stock has rallied 74.6% compared with its industry’s growth of 21.2%.
Be among the early investors in the new type of device that experts say could impact society as much as the discovery of electricity. Current technology will soon be outdated and replaced by these new devices. In the process, it’s expected to create 22 million jobs and generate $12.3 trillion in activity.
A select few stocks could skyrocket the most as rollout accelerates for this new tech. Early investors could see gains similar to buying Microsoft in the 1990s. Zacks’ just-released special report reveals 8 stocks to watch. The report is only available for a limited time. See 8 breakthrough stocks now>>
Unique Zacks Analysis of Your Chosen Ticker
Pick one free report - opportunity may be withdrawn at any time
Image: Bigstock
Ensign Group (ENSG) Hits 52 Week High: Will the Rally Continue?
On Dec 7, shares of The Ensign Group, Inc. (ENSG - Free Report) touched a 52-week high of $73.98 before closing the session a tad lower at $73.87.
This upside can be attributed to investors’ confidence in the company’s ability to gain from its strong inorganic story that it has created over the past decade. In fact, investors’ optimism was buoyed by the company’s 2020 guidance raise despite the current economic scenario.
For the full year, earnings guidance is expected between $3.04 and $3.12, up from the previous view of $3-$3.10. The midpoint of this lifted outlook indicates a 58% rise from the 2019 adjusted results.
What’s Driving This Outperformance?
Recently, the company completed the buyout of operations of a San Marcos, TX-based skilled nursing facility, which contains 116 beds. The inclusion of Hays Nursing and Rehabilitation Center brings the total count of healthcare operations in the company’s portfolio to 228, which is spread across 13 states. Subject to a long-term, triple net lease, the transaction has already been effective since Dec 1, 2020. Significantly, last month, the company bought the real estate and operations of a Texas-based skilled nursing facility named The Medical Lodge of Amarillo.
It used acquisitions to supplement its organic efforts. These buyouts also proved to be accretive to its revenues and allowed it to grow in scale and size. The company’s historical growth is mainly driven by its expertise in acquiring real estate or leasing post-acute care operations and transforming the same into market leaders. Each acquisition sharpened its efficiency, both clinically and financially.
Ensign Group continues to actively seek transactions to purchase real estate and to lease both well-performing and struggling skilled nursing, assisted living and other healthcare-related businesses in the new and existing markets. There are already several buyouts in its pipeline, which are expected to close in the fourth quarter of 2020 and early 2021.
Its top line has been growing on the back of both its Medicaid and Medicare businesses. It also anticipates 2020 annual revenues in the band of $2.42-$2.45 billion, the midpoint implying an upside of 6.3% from the year-ago reported figure.
Ensign Group is well poised for growth owing to its strategic measures as well as a solid capital position.
We believe that these efforts will continue to augur well for the company in the long haul.
Its earnings estimate stands at $3.06, suggesting a 36.6% surge from the prior-year reported number.
The company carries a Zacks Rank #3 (Hold ), currently. Over the past year, the stock has rallied 74.6% compared with its industry’s growth of 21.2%.
Other companies in the same space, such as Acadia Healthcare Company, Inc. (ACHC - Free Report) , UnitedHealth Group Incorporated (UNH - Free Report) and Community Health Systems, Inc. (CYH - Free Report) have also gained 32%, 25.3% and 127.7%, respectively, over the same time frame. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Biggest Tech Breakthrough in a Generation
Be among the early investors in the new type of device that experts say could impact society as much as the discovery of electricity. Current technology will soon be outdated and replaced by these new devices. In the process, it’s expected to create 22 million jobs and generate $12.3 trillion in activity.
A select few stocks could skyrocket the most as rollout accelerates for this new tech. Early investors could see gains similar to buying Microsoft in the 1990s. Zacks’ just-released special report reveals 8 stocks to watch. The report is only available for a limited time.
See 8 breakthrough stocks now>>